<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="pcmr13199" xml:lang="en" article-type="brief-report"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Pigment Cell Melanoma Res</journal-id><journal-id journal-id-type="iso-abbrev">Pigment Cell Melanoma Res</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1755-148X</journal-id><journal-id journal-id-type="publisher-id">PCMR</journal-id><journal-title-group><journal-title>Pigment Cell &#x00026; Melanoma Research</journal-title></journal-title-group><issn pub-type="ppub">1755-1471</issn><issn pub-type="epub">1755-148X</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39315505</article-id><article-id pub-id-type="pmc">PMC11681841</article-id>
<article-id pub-id-type="doi">10.1111/pcmr.13199</article-id><article-id pub-id-type="publisher-id">PCMR13199</article-id><article-id pub-id-type="other">24-SC-084.R1</article-id><article-categories><subj-group subj-group-type="overline"><subject>Short Communication</subject></subj-group><subj-group subj-group-type="heading"><subject>Short Communication</subject></subj-group></article-categories><title-group><article-title>Germline Variants in Patients Affected by Both Uveal and Cutaneous Melanoma</article-title></title-group><contrib-group><contrib id="pcmr13199-cr-0001" contrib-type="author" corresp="yes"><name><surname>Johansson</surname><given-names>Peter A.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7015-5452</contrib-id><xref rid="pcmr13199-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="pcmr13199-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><address><email>peter.johansson@qimrberghofer.edu.au</email></address></contrib><contrib id="pcmr13199-cr-0002" contrib-type="author"><name><surname>Palmer</surname><given-names>Jane M.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2702-522X</contrib-id><xref rid="pcmr13199-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="pcmr13199-cr-0003" contrib-type="author"><name><surname>McGrath</surname><given-names>Lindsay</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0925-1124</contrib-id><xref rid="pcmr13199-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="pcmr13199-cr-0004" contrib-type="author"><name><surname>Warrier</surname><given-names>Sunil</given-names></name><xref rid="pcmr13199-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="pcmr13199-cr-0005" contrib-type="author"><name><surname>Hamilton</surname><given-names>Hayley R.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5899-1458</contrib-id><xref rid="pcmr13199-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="pcmr13199-cr-0006" contrib-type="author"><name><surname>Beckman</surname><given-names>Timothy</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8364-9643</contrib-id><xref rid="pcmr13199-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="pcmr13199-cr-0007" contrib-type="author"><name><surname>D'Mellow</surname><given-names>Matthew G.</given-names></name><xref rid="pcmr13199-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="pcmr13199-cr-0008" contrib-type="author"><name><surname>Brooks</surname><given-names>Kelly M.</given-names></name><xref rid="pcmr13199-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="pcmr13199-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="pcmr13199-cr-0009" contrib-type="author"><name><surname>Glasson</surname><given-names>William</given-names></name><xref rid="pcmr13199-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="pcmr13199-cr-0010" contrib-type="author"><name><surname>Hayward</surname><given-names>Nicholas K.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4760-1033</contrib-id><xref rid="pcmr13199-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="pcmr13199-cr-0011" contrib-type="author"><name><surname>Pritchard</surname><given-names>Antonia L.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5336-0454</contrib-id><xref rid="pcmr13199-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="pcmr13199-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib></contrib-group><aff id="pcmr13199-aff-0001">
<label>
<sup>1</sup>
</label>
<institution>QIMR Berghofer Medical Research Institute</institution>
<city>Brisbane</city>
<named-content content-type="country-part">Queensland</named-content>
<country country="AU">Australia</country>
</aff><aff id="pcmr13199-aff-0002">
<label>
<sup>2</sup>
</label>
<institution>University of Queensland</institution>
<city>Brisbane</city>
<named-content content-type="country-part">Queensland</named-content>
<country country="AU">Australia</country>
</aff><aff id="pcmr13199-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Queensland Ocular Oncology Service</named-content>
<institution>The Terrace Eye Centre</institution>
<city>Brisbane</city>
<named-content content-type="country-part">Queensland</named-content>
<country country="AU">Australia</country>
</aff><aff id="pcmr13199-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Department of Genetics and Immunology, Division of Biomedical Science</named-content>
<institution>University of the Highlands and Islands</institution>
<city>Inverness</city>
<named-content content-type="country-part">Scotland</named-content>
<country country="GB">UK</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence:</bold>
<break/>
Peter A. Johansson (<email>peter.johansson@qimrberghofer.edu.au</email>)<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>24</day><month>9</month><year>2024</year></pub-date><pub-date pub-type="ppub"><month>1</month><year>2025</year></pub-date><volume>38</volume><issue seq="190">1</issue><issue-id pub-id-type="doi">10.1111/pcmr.v38.1</issue-id><elocation-id>e13199</elocation-id><history>
<date date-type="rev-recd"><day>15</day><month>8</month><year>2024</year></date>
<date date-type="received"><day>12</day><month>5</month><year>2024</year></date>
<date date-type="accepted"><day>03</day><month>9</month><year>2024</year></date>
</history><permissions><!--Copyright &#x000a9; 2025 John Wiley & Sons A/S--><copyright-statement content-type="article-copyright">&#x000a9; 2024 The Author(s). <italic toggle="yes">Pigment Cell &#x00026; Melanoma Research</italic> published by John Wiley &#x00026; Sons Ltd.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:PCMR-38-0.pdf"/><abstract><title>ABSTRACT</title><p>Uveal melanoma (UM) and nonacral cutaneous melanoma (CM) are distinct entities with varied genetic landscapes despite both arising from melanocytes. There are, however, similarities in that they most frequently affect people of European ancestry, and high penetrance germline variants in <italic toggle="no">BAP1</italic>, <italic toggle="no">POT1</italic> and <italic toggle="no">CDKN2A</italic> have been shown to predispose to both UM and CM. This study aims to further explore germline variants in patients affected by both UM and CM, shedding light on the underlying genetic mechanism causing these diseases. Using exome sequencing we analysed germline DNA samples from a cohort of 83 Australian patients diagnosed with both UM and CM. Eight (10%) patients were identified that carried pathogenic mutations in known melanoma predisposition genes <italic toggle="no">POT1</italic>, <italic toggle="no">MITF</italic>, <italic toggle="no">OCA2</italic>, <italic toggle="no">SLC45A2</italic> and <italic toggle="no">TYR</italic>. Three (4%) patients carried pathogenic variants in genes previously linked with other cancer syndromes (<italic toggle="no">ATR</italic>, <italic toggle="no">BRIP1</italic> and <italic toggle="no">MSH6</italic>) and another three cases carried monoallelic pathogenic variants in recessive cancer genes (xeroderma pigmentosum and Fanconi anaemia), indicating that reduced penetrance of phenotype in these individuals may contribute to the development of both UM and CM. These findings highlight the need for further studies characterising the role of these genes in melanoma susceptibility.</p></abstract><abstract abstract-type="graphical"><p>Germline variants predisposing uveal and cutaneous melanoma are identified using exome sequencing. Created with <ext-link xlink:href="https://biorender.com" ext-link-type="uri">BioRender.com</ext-link>.<boxed-text position="anchor" content-type="graphic" id="pcmr13199-blkfxd-0001"><graphic xlink:href="PCMR-38-0-g001.jpg" position="anchor" id="jats-graphic-1"/></boxed-text>
</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="pcmr13199-kwd-0001">cutaneous melanoma</kwd><kwd id="pcmr13199-kwd-0002">genetic risk</kwd><kwd id="pcmr13199-kwd-0003">germline variants</kwd><kwd id="pcmr13199-kwd-0004">sequencing</kwd><kwd id="pcmr13199-kwd-0005">uveal melanoma</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>Glen Law</funding-source></award-group><award-group id="funding-0002"><funding-source><institution-wrap><institution>Highlands and Islands Enterprise
</institution><institution-id institution-id-type="doi">10.13039/100008239</institution-id></institution-wrap></funding-source></award-group><award-group id="funding-0003"><funding-source><institution-wrap><institution>National Health and Medical Research Council
</institution><institution-id institution-id-type="doi">10.13039/501100000925</institution-id></institution-wrap></funding-source></award-group><award-group id="funding-0004"><funding-source>the St Mary&#x02019;s Anglican Parish of Kangaroo Point</funding-source></award-group><award-group id="funding-0005"><funding-source>Buck Off Melanoma</funding-source></award-group></funding-group><counts><fig-count count="1"/><table-count count="2"/><page-count count="6"/><word-count count="4900"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>January 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.1 mode:remove_FC converted:28.12.2024</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group id="pcmr13199-ntgp-0001"><fn fn-type="funding" id="pcmr13199-note-0001"><p>
<bold>Funding:</bold> This study was supported by the Glen Law; Highlands and Islands Enterprise; National Health and Medical Research Council; the St Mary's Anglican Parish of Kangaroo Point; Buck Off Melanoma.</p></fn></fn-group></notes></front><body id="pcmr13199-body-0001"><p>
<boxed-text position="anchor" content-type="box" id="pcmr13199-blkfxd-0002"><caption><title>Summary</title></caption><p>
<list list-type="bullet" id="pcmr13199-list-0001"><list-item id="pcmr13199-li-0001"><p>This study explored the genetic variants in individuals affected by both uveal and cutaneous melanoma.</p></list-item><list-item id="pcmr13199-li-0002"><p>It confirmed that both subtypes are part of the <italic toggle="yes">POT1</italic> tumour predisposition syndrome spectrum.</p></list-item><list-item id="pcmr13199-li-0003"><p>Variants in established cutaneous melanoma genes were observed, suggesting they could also predispose to uveal melanoma.</p></list-item><list-item id="pcmr13199-li-0004"><p>Some patients carried variants in genes previously linked to other cancers, potentially expanding the disease spectra pathogenic variants in these genes predispose to.</p></list-item></list>
</p></boxed-text>
</p><sec sec-type="opening-section" id="pcmr13199-sec-0021"><p>Uveal melanoma (UM) originates from melanocytes in the uveal tract of the eye and differs from cutaneous melanoma (CM) in anatomical location, molecular drivers and clinical characteristics. CM arise from the melanocytes in the layer of basal cells at the deepest part of the epidermis of the skin and when occurring in nonglabrous skin are frequently driven by exposure to ultraviolet (UV) radiation. While immunotherapy has radically changed the outcome of advanced&#x02010;stage CM, its success has been more limited in UM (Nathan, Hassel, et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0034" ref-type="bibr">2021</xref>). This discrepancy can be partly attributed to the considerably lower tumour mutation burden in UM (Newell et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0038" ref-type="bibr">2022</xref>; Rizvi et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0041" ref-type="bibr">2015</xref>), but differences in the tumour microenvironment might also contribute. CM often exhibit hotspot mutations in <italic toggle="yes">NRAS</italic> or <italic toggle="yes">BRAF</italic>, which constitutively activate the mitogen&#x02010;activated protein kinase (MAPK) pathway. In contrast, UM frequently harbours mutations in <italic toggle="yes">GNAQ</italic> or <italic toggle="yes">GNA11</italic>, which activate the G&#x02010;protein signalling pathway. These differences underscore the distinct molecular pathways driving the development of UM and CM.</p><p>Despite these differences, there are also some similarities, particularly in factors influencing predisposition. Epidemiological studies have shown that UM and (nonacral) CM most frequently affect people of European ancestry. In CM, this association is caused by fair skin, offering less protection against mutagenic UV radiation (Del Bino, Sok, and Bernerd&#x000a0;<xref rid="pcmr13199-bib-0009" ref-type="bibr">2013</xref>), supported by genome&#x02010;wide association studies of CM, which have identified numerous susceptibility loci near pigmentation genes (Landi et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0023" ref-type="bibr">2020</xref>). Similarly, smaller association studies have identified four loci associated with UM (Ferguson et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0011" ref-type="bibr">2016</xref>; Mobuchon et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0032" ref-type="bibr">2017</xref>, <xref rid="pcmr13199-bib-0033" ref-type="bibr">2022</xref>; Thomsen et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0048" ref-type="bibr">2020</xref>), with three overlapping CM susceptibility regions, including the loci at <italic toggle="yes">IRF4</italic> and <italic toggle="yes">HERC2</italic>/<italic toggle="yes">OCA2</italic> linked with pigmentation and the <italic toggle="yes">TERT</italic>/<italic toggle="yes">CLPTM1L</italic> locus associated with telomere regulation (Derrien et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0010" ref-type="bibr">2022</xref>). This suggests an overlap in the molecular mechanisms underlying CM and UM tumorigenesis, which is further supported by shared rare high penetrance variants predisposing to both tumour types in families. Protein&#x02010;truncating variants (PTVs) in <italic toggle="yes">BAP1</italic> dramatically increase the risk for both UM and CM (Abdel&#x02010;Rahman et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0001" ref-type="bibr">2011</xref>), as part of the BAP1 tumour predisposition syndrome (Walpole et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0051" ref-type="bibr">2018</xref>) and variants in <italic toggle="yes">POT1</italic> and <italic toggle="yes">CDKN2A</italic> predispose to CM (Robles&#x02010;Espinoza et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0043" ref-type="bibr">2014</xref>), while case reports have suggested that <italic toggle="yes">POT1</italic> and <italic toggle="yes">CDKN2A</italic> are risk genes for UM (Hearle et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0015" ref-type="bibr">2003</xref>; Kannengiesser et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0018" ref-type="bibr">2003</xref>; Nathan et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0037" ref-type="bibr">2021</xref>), although with limited penetrance (Abdel&#x02010;Rahman et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0002" ref-type="bibr">2020</xref>).</p><p>Given these shared aetiologies, we hypothesised that other yet to be identified germline variants predispose to both UM and CM. To explore this, we recruited 83 patients attending a single Australian ocular oncology referral centre diagnosed with both UM and CM and performed genome or exome sequencing.</p><p>This study was approved by the Human Research Ethics Committee of the QIMR Berghofer Medical Research Institute (HREC/14/QPAH/495). Blood or saliva samples were collected with informed written consent. Blood DNA was extracted using standard salting&#x02010;out methods, and saliva DNA was extracted using Oragene DNA kits (OG&#x02010;500; DNA Genotek, Ottawa, Canada) according to the manufacturer's instructions. Genome and exome (using SureSelect V7 postcapture kits) sequencing was conducted by Macrogen (Seoul, South Korea) on the Illumina platform. The resulting sequence reads were aligned to the HumanG1Kv37 assembly using the Burrows&#x02010;Wheeler Aligner (BWA&#x02010;MEM) (Li and Durbin&#x000a0;<xref rid="pcmr13199-bib-0026" ref-type="bibr">2010</xref>) and duplicate reads were identified by Picard v1.141 (<ext-link xlink:href="https://broadinstitute.github.io/picard/" ext-link-type="uri">https://broadinstitute.github.io/picard/</ext-link>). To enhance the alignments, reads were realigned against common insertions and deletions and base qualities were calibrated using the Genome Analysis Toolkit (GATK) (McKenna et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0029" ref-type="bibr">2010</xref>). Small substitutions were detected with bcftools (Li and Durbin&#x000a0;<xref rid="pcmr13199-bib-0025" ref-type="bibr">2009</xref>), while indels were detected using Pindel (Ye et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0052" ref-type="bibr">2009</xref>), and annotated using the Ensembl Variant Effect Predictor (VEP) (McLaren et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0030" ref-type="bibr">2016</xref>) including Sorting Intolerant From Tolerant (SIFT) and Polymorphism Phenotyping v2 (PolyPhen2) predictions (Adzhubei, Jordan, and Sunyaev&#x000a0;<xref rid="pcmr13199-bib-0004" ref-type="bibr">2013</xref>; Ng and Henikoff&#x000a0;<xref rid="pcmr13199-bib-0039" ref-type="bibr">2003</xref>) and variant allele frequencies (VAFs) from the Genome Aggregate Database (gnomAD) (Karczewski et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0019" ref-type="bibr">2020</xref>), and variants were subsequently annotated with Combined Annotation Dependent Depletion (CADD) (Kircher et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0020" ref-type="bibr">2014</xref>), Rare Exome Variant Ensemble Learner (REVEL) (Ioannidis et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0017" ref-type="bibr">2016</xref>) and MetaRNN (Li et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0024" ref-type="bibr">2022</xref>) predictions using dbNSFP v4.8 (Liu et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0027" ref-type="bibr">2020</xref>), with CI&#x02010;SpliceAI predictions (Strauch et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0046" ref-type="bibr">2022</xref>), and with ClinVar data (downloaded 2 May 2024). High&#x02010;quality variants were identified by requiring at least three variant reads and phred&#x02010;scaled likelihood for wildtype &#x0003e;&#x02009;70. We removed variants that were located in segmentally duplicated regions (Bailey et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0005" ref-type="bibr">2002</xref>), showed strand bias (<italic toggle="yes">p</italic>&#x02009;&#x0003c; 1&#x02009;&#x000d7; 10<sup>&#x02212;4</sup>), tail distance bias (<italic toggle="yes">p</italic>&#x02009;&#x0003c; 1&#x02009;&#x000d7; 10<sup>&#x02212;4</sup>), clustered near the end of the reads (&#x0003c;&#x02009;10%), or if the variant reads had substantially lower average mapping quality than the wild&#x02010;type reads (&#x0003e; 30). Nonsynonymous <italic toggle="yes">MC1R</italic> variants were categorised into R alleles, strongly associated with red hair, and r alleles weakly associated with red hair, as described elsewhere (Robles&#x02010;Espinoza et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0044" ref-type="bibr">2016</xref>; Valverde et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0049" ref-type="bibr">1995</xref>).</p><p>Of the 83 patients, 42 (51%) were male. The median age at diagnosis of the first CM was 64.9&#x02009;years (range 22.4&#x02013;89.1) and for UM was 67.7&#x02009;years (range 27.3&#x02013;90.1); (Table&#x000a0;<xref rid="pcmr13199-tbl-0001" ref-type="table">1</xref>; Table&#x000a0;<xref rid="pcmr13199-supitem-0001" ref-type="supplementary-material">S1</xref>). One patient with a particularly notable history of bilateral UM (56 and 73&#x02009;years) and three CMs had no coding region mutation that could be linked with a heightened melanoma risk.</p><table-wrap position="float" id="pcmr13199-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>Patient characteristics.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><tbody valign="top"><tr style="border-bottom:solid 1px #000000"><td align="left" valign="top" rowspan="1" colspan="1">Sex, male (%)</td><td align="center" valign="top" rowspan="1" colspan="1">42 (51)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Number of CM, mean (range)</td><td align="center" valign="top" rowspan="1" colspan="1">1.57 (1&#x02013;7)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Onset age 1st CM, median (range)</td><td align="center" valign="top" rowspan="1" colspan="1">64.9 (22.4&#x02013;89.1)</td></tr><tr><td align="left" colspan="2" valign="top" rowspan="1">CM Histotype, <italic toggle="yes">n</italic> (%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Malignant melanoma, NOS</td><td align="center" valign="top" rowspan="1" colspan="1">29 (22)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Melanoma in&#x000a0;situ</td><td align="center" valign="top" rowspan="1" colspan="1">31 (24)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Nodular melanoma</td><td align="center" valign="top" rowspan="1" colspan="1">7 (5.4)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Superficial spreading melanoma</td><td align="center" valign="top" rowspan="1" colspan="1">30 (23)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Superficial spreading melanoma in&#x000a0;situ</td><td align="center" valign="top" rowspan="1" colspan="1">30 (23)</td></tr><tr><td align="left" colspan="2" valign="top" rowspan="1">CM Primary site, <italic toggle="yes">n</italic> (%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Face</td><td align="center" valign="top" rowspan="1" colspan="1">6 (4.7)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Lower limb (including hip)</td><td align="center" valign="top" rowspan="1" colspan="1">25 (20)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Scalp and neck</td><td align="center" valign="top" rowspan="1" colspan="1">12 (9.4)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Trunk</td><td align="center" valign="top" rowspan="1" colspan="1">44 (35)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Upper limb (including shoulder)</td><td align="center" valign="top" rowspan="1" colspan="1">40 (31)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Number of UM, mean (range)</td><td align="center" valign="top" rowspan="1" colspan="1">1.01 (1&#x02013;2)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Onset age 1st UM, median (range)</td><td align="center" valign="top" rowspan="1" colspan="1">67.7 (27.3&#x02013;90.1)</td></tr><tr><td align="left" colspan="2" valign="top" rowspan="1">UM Primary site, <italic toggle="yes">n</italic> (%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Choroid</td><td align="center" valign="top" rowspan="1" colspan="1">63 (75)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Ciliary body</td><td align="center" valign="top" rowspan="1" colspan="1">21 (25)</td></tr><tr><td align="left" colspan="2" valign="top" rowspan="1">
<italic toggle="yes">MC1R</italic>, <italic toggle="yes">n</italic> (%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Wildtype</td><td align="center" valign="top" rowspan="1" colspan="1">15 (18)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">r/0</td><td align="center" valign="top" rowspan="1" colspan="1">16 (19)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">r/r</td><td align="center" valign="top" rowspan="1" colspan="1">8 (9.6)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">R/0</td><td align="center" valign="top" rowspan="1" colspan="1">22 (27)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">R/r</td><td align="center" valign="top" rowspan="1" colspan="1">14 (17)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">R/R</td><td align="center" valign="top" rowspan="1" colspan="1">8 (9.6)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Relatives with cancer, mean (range)</td><td align="center" valign="top" rowspan="1" colspan="1">1.4 (0&#x02013;12)</td></tr></tbody></table><table-wrap-foot id="pcmr13199-ntgp-0002"><fn id="pcmr13199-note-0002"><p>
<italic toggle="yes">Note:</italic> Characteristics of the patient cohort including number of, histotype and location of cutaneous melanoma (CM) and uveal melanoma (UM). R alleles of <italic toggle="yes">MC1R</italic> are strongly associated with red hair colour, while r alleles and wildtype (0) are not. Near relatives include first and second&#x02010;degree relatives with confirmed diagnosis of cancer. See also Table&#x000a0;<xref rid="pcmr13199-supitem-0001" ref-type="supplementary-material">S1</xref>.</p></fn></table-wrap-foot></table-wrap><p>Next, we investigated variants in established melanoma predisposition genes. Two patients carried variants in <italic toggle="yes">POT1</italic> (c.1851_1852del p.(D617Efs*9), c.670G&#x0003e;A p.(D224N)). The p.(D224N) variant was classified in ClinVar as variant of uncertain significance (VUS), but notably it has previously been observed in familial melanoma and patients with multiple primary melanomas (Shi et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0045" ref-type="bibr">2014</xref>). The p.(D617Efs*9) variant had conflicting classifications in ClinVar as submitters had classified it as VUS and likely pathogenic. Both variants have been described in several other cancer patients, including those with glioma, colorectal and lung cancer (reviewed in Nathan et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0035" ref-type="bibr">2021</xref>), and we therefore consider them likely to result in a loss of POT1, which contributes to the melanoma risk. Six patients carried pathogenic variants in genes known to be associated with CM, including <italic toggle="yes">MITF</italic> (c.952G&#x0003e;A p.(E318K)), <italic toggle="yes">OCA2</italic> (c.1327G&#x0003e;A p.(V443I)), <italic toggle="yes">SLC45A2</italic> (c.606G&#x0003e;C p.(W202C), c.834C&#x0003e;G p.(T278*)) and <italic toggle="yes">TYR</italic> (c.626C&#x0003e;T p.(P209L), c.1118C&#x0003e;A p.(T373K)) (Bertolotto et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0007" ref-type="bibr">2011</xref>; Nathan et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0036" ref-type="bibr">2019</xref>; Yokoyama et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0053" ref-type="bibr">2011</xref>) (Table&#x000a0;<xref rid="pcmr13199-tbl-0002" ref-type="table">2</xref>, Table&#x000a0;<xref rid="pcmr13199-supitem-0002" ref-type="supplementary-material">S2</xref>). Another 17 variants, classified as conflicting or VUS in ClinVar, were observed in genes associated with CM: <italic toggle="yes">ATM</italic>, <italic toggle="yes">BAP1, MITF</italic>, <italic toggle="yes">OCA2</italic>, <italic toggle="yes">POT1</italic>, <italic toggle="yes">SLC45A2</italic> and <italic toggle="yes">TERT</italic> (Table&#x000a0;<xref rid="pcmr13199-supitem-0002" ref-type="supplementary-material">S2</xref>). These genes are mostly involved in pigmentation; therefore, variants could affect the level of protection against UV radiation. A gene strongly associated with pigmentation is <italic toggle="yes">MC1R</italic>. Patients with a history of CM and UM had on average 0.63 <italic toggle="yes">MC1R</italic> R alleles, almost identical to a cohort of CM patients (0.64), and more frequent than in a UM cohort (0.48) (Newell et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0038" ref-type="bibr">2022</xref>). The observation that R alleles are more common in CM than UM (Fisher's exact, <italic toggle="yes">p&#x02009;=</italic>&#x02009;0.03) is consistent with R alleles (associated with red hair, pale skin and poor tanning ability) not being associated with UM risk but strongly associated with the development of CM (Landi et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0023" ref-type="bibr">2020</xref>).</p><table-wrap position="float" id="pcmr13199-tbl-0002" content-type="TABLE"><label>TABLE 2</label><caption><p>Selected variants.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Sample ID</th><th align="center" valign="bottom" rowspan="1" colspan="1">Gene</th><th align="center" valign="bottom" rowspan="1" colspan="1">Amino acid change<xref rid="pcmr13199-note-0009" ref-type="table-fn">
<sup>e</sup>
</xref>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">ClinVar classification<xref rid="pcmr13199-note-0010" ref-type="table-fn">
<sup>f</sup>
</xref>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">GnomAD VAF<xref rid="pcmr13199-note-0011" ref-type="table-fn">
<sup>g</sup>
</xref>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">Recessive disorder</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">MELA_0959</td><td align="center" valign="top" rowspan="1" colspan="1">ATR<xref rid="pcmr13199-note-0005" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">p.(I774Nfs*3)</td><td align="center" valign="top" rowspan="1" colspan="1">PV or LPV</td><td align="center" valign="top" rowspan="1" colspan="1">4.7&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MELA_0927</td><td align="center" valign="top" rowspan="1" colspan="1">BRIP1<xref rid="pcmr13199-note-0006" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">p.(R798*)</td><td align="center" valign="top" rowspan="1" colspan="1">PV or LPV</td><td align="center" valign="top" rowspan="1" colspan="1">2.0&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MELA_0940</td><td align="center" valign="top" rowspan="1" colspan="1">MITF<xref rid="pcmr13199-note-0005" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">p.(E318K)</td><td align="center" valign="top" rowspan="1" colspan="1">PV or LPV; RF</td><td align="center" valign="top" rowspan="1" colspan="1">2.4&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MELA_0927</td><td align="center" valign="top" rowspan="1" colspan="1">MSH6<xref rid="pcmr13199-note-0006" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">p.(R1076C)</td><td align="center" valign="top" rowspan="1" colspan="1">LPV</td><td align="center" valign="top" rowspan="1" colspan="1">3.1&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MELA_0886</td><td align="center" valign="top" rowspan="1" colspan="1">MSH6<xref rid="pcmr13199-note-0006" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">p.(R1076C)</td><td align="center" valign="top" rowspan="1" colspan="1">LPV</td><td align="center" valign="top" rowspan="1" colspan="1">3.1&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MELA_0919</td><td align="center" valign="top" rowspan="1" colspan="1">POT1<xref rid="pcmr13199-note-0007" ref-type="table-fn">
<sup>c</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">p.(D617Efs*9)</td><td align="center" valign="top" rowspan="1" colspan="1">CC</td><td align="center" valign="top" rowspan="1" colspan="1">3.1&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MELA_0921</td><td align="center" valign="top" rowspan="1" colspan="1">POT1<xref rid="pcmr13199-note-0007" ref-type="table-fn">
<sup>c</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">p.(D224N)</td><td align="center" valign="top" rowspan="1" colspan="1">VUS</td><td align="center" valign="top" rowspan="1" colspan="1">2.0&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MELA_0928</td><td align="center" valign="top" rowspan="1" colspan="1">ERCC5<xref rid="pcmr13199-note-0006" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">p.(K917Nfs*65)</td><td align="center" valign="top" rowspan="1" colspan="1">PV</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">XP<xref rid="pcmr13199-note-0012" ref-type="table-fn">
<sup>h</sup>
</xref> group G</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MELA_0941</td><td align="center" valign="top" rowspan="1" colspan="1">FANCE<xref rid="pcmr13199-note-0006" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">p.(R371W)</td><td align="center" valign="top" rowspan="1" colspan="1">PV or LPV</td><td align="center" valign="top" rowspan="1" colspan="1">6.2&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1">Fanconi anaemia</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MELA_0951</td><td align="center" valign="top" rowspan="1" colspan="1">OCA2<xref rid="pcmr13199-note-0005" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">p.(V443I)</td><td align="center" valign="top" rowspan="1" colspan="1">PV or LPV</td><td align="center" valign="top" rowspan="1" colspan="1">6.1&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1">Oculocutaneous albinism type 2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MELA_0907</td><td align="center" valign="top" rowspan="1" colspan="1">SLC45A2<xref rid="pcmr13199-note-0005" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">p.(Y278*)</td><td align="center" valign="top" rowspan="1" colspan="1">PV or LPV</td><td align="center" valign="top" rowspan="1" colspan="1">1.0&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1">Oculocutaneous albinism type 4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MELA_0926</td><td align="center" valign="top" rowspan="1" colspan="1">SLC45A2<xref rid="pcmr13199-note-0005" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">p.(W202C)</td><td align="center" valign="top" rowspan="1" colspan="1">PV or LPV</td><td align="center" valign="top" rowspan="1" colspan="1">1.0&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1">Oculocutaneous albinism type 4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MELA_0936</td><td align="center" valign="top" rowspan="1" colspan="1">TYR<xref rid="pcmr13199-note-0005" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">p.(P209L)</td><td align="center" valign="top" rowspan="1" colspan="1">PV</td><td align="center" valign="top" rowspan="1" colspan="1">1.5&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1">Oculocutaneous albinism types 1, 3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MELA_0927</td><td align="center" valign="top" rowspan="1" colspan="1">TYR<xref rid="pcmr13199-note-0005" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">p.(T373K)</td><td align="center" valign="top" rowspan="1" colspan="1">PV</td><td align="center" valign="top" rowspan="1" colspan="1">1.0&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1">Oculocutaneous albinism types 1, 3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MELA_0888</td><td align="center" valign="top" rowspan="1" colspan="1">WRN<xref rid="pcmr13199-note-0008" ref-type="table-fn">
<sup>d</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">p.(D77H)</td><td align="center" valign="top" rowspan="1" colspan="1">VUS</td><td align="center" valign="top" rowspan="1" colspan="1">5.0&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1">Werner syndrome</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MELA_0950</td><td align="center" valign="top" rowspan="1" colspan="1">WRN<xref rid="pcmr13199-note-0008" ref-type="table-fn">
<sup>d</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">p.(R711W)</td><td align="center" valign="top" rowspan="1" colspan="1">CC</td><td align="center" valign="top" rowspan="1" colspan="1">3.0&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1">Werner syndrome</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MELA_0944</td><td align="center" valign="top" rowspan="1" colspan="1">WRN<xref rid="pcmr13199-note-0008" ref-type="table-fn">
<sup>d</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">p.(H916P)</td><td align="center" valign="top" rowspan="1" colspan="1">VUS</td><td align="center" valign="top" rowspan="1" colspan="1">2.0&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1">Werner syndrome</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MELA_0955</td><td align="center" valign="top" rowspan="1" colspan="1">WRN<xref rid="pcmr13199-note-0008" ref-type="table-fn">
<sup>d</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">p.(I1145T)</td><td align="center" valign="top" rowspan="1" colspan="1">VUS</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">Werner syndrome</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MELA_0910</td><td align="center" valign="top" rowspan="1" colspan="1">XPA<xref rid="pcmr13199-note-0006" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">p.(M1?)</td><td align="center" valign="top" rowspan="1" colspan="1">LPV</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">XP<xref rid="pcmr13199-note-0012" ref-type="table-fn">
<sup>h</sup>
</xref> group A</td></tr></tbody></table><table-wrap-foot id="pcmr13199-ntgp-0003"><fn id="pcmr13199-note-0003"><p>
<italic toggle="yes">Note:</italic> See also Table&#x000a0;<xref rid="pcmr13199-supitem-0002" ref-type="supplementary-material">S2</xref> for more details.</p></fn><fn id="pcmr13199-note-0004"><p>Abbreviations: CC, conflicting classifications; LPV, likely pathogenic variant; PV, pathogenic variant; RF, risk factor; VUS, variant of uncertain significance.</p></fn><fn id="pcmr13199-note-0005"><label>
<sup>a</sup>
</label><p>Gene associated with cutaneous melanoma.</p></fn><fn id="pcmr13199-note-0006"><label>
<sup>b</sup>
</label><p>Gene associated with various cancers.</p></fn><fn id="pcmr13199-note-0007"><label>
<sup>c</sup>
</label><p>Gene linked with cutaneous and uveal melanoma.</p></fn><fn id="pcmr13199-note-0008"><label>
<sup>d</sup>
</label><p>Gene linked with acral melanoma.</p></fn><fn id="pcmr13199-note-0009"><label>
<sup>e</sup>
</label><p>The variant's predicted change in the protein encoded by the MANE select transcript except for MITF for which the change is displayed in the protein mainly expressed in melanoma, NP_000239.1.</p></fn><fn id="pcmr13199-note-0010"><label>
<sup>f</sup>
</label><p>The aggregate classification in the ClinVar database as of 2<sup>nd</sup> May 2024.</p></fn><fn id="pcmr13199-note-0011"><label>
<sup>g</sup>
</label><p>The variant allele frequency in the non&#x02010;Finnish European population in version 3 of the Genome Aggregation Database.</p></fn><fn id="pcmr13199-note-0012"><label>
<sup>h</sup>
</label><p>Xeroderma pigmentosum.</p></fn></table-wrap-foot></table-wrap><p>Four patients carried rare (gnomAD VAF &#x02264;&#x02009;5&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup>) missense variants in <italic toggle="yes">WRN</italic> (c.229G&#x0003e;C p.(D77H), c.2131C&#x0003e;T p.(R711W), c.2747A&#x0003e;C p.(H916P), c.3434T&#x0003e;C p.(I1145T)), a gene associated with Werner syndrome and acral melanoma (Goto et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0013" ref-type="bibr">1996</xref>; Newell et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0038" ref-type="bibr">2022</xref>). The majority of in silico predictions for p.(D77H) and p.(I1145T) were benign, 3/5 were pathogenic for p.(R711W), and 4/5 were pathogenic for p.(H916P), consistent with that the p.(H916P) variant affects a highly conserved region within the functionally crucial zinc&#x02010;binding subdomain (Kitano&#x000a0;<xref rid="pcmr13199-bib-0021" ref-type="bibr">2014</xref>).</p><p>Next, we investigated genes with common somatic alterations in melanoma. Three patients carried rare missense variants in <italic toggle="yes">GNAQ</italic> (c.93G&#x0003e;C p.(R31S)) or its paralogue <italic toggle="yes">GNA11</italic> (c.323C&#x0003e;G p.(A108G), c.434A&#x0003e;T p.(Y145F)), two genes typically associated with driving the development of UM via mutations at hotspots p.R183 and p.Q209 (Robertson et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0042" ref-type="bibr">2017</xref>; Van Raamsdonk et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0050" ref-type="bibr">2010</xref>). Most in silico predictions were benign for these variants (Table&#x000a0;<xref rid="pcmr13199-supitem-0002" ref-type="supplementary-material">S2</xref>) except that <italic toggle="yes">GNA11</italic> p.(Y145F) was predicted pathogenic by 3/5 tools, which suggests it possibly alters the protein function and contributes to the melanoma risk.</p><p>Three patients carried four variants in <italic toggle="yes">SPRED1</italic>, which encodes a tumour suppressor regulating the MAPK pathway and is often disrupted through somatic mutations in mucosal melanoma (Ablain et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0003" ref-type="bibr">2018</xref>). One individual carried c.875A&#x0003e;G p.(Y292C) and c.887G&#x0003e;A p.(C296Y) variants on the same chromosome, in line with gnomAD data in which these two variants always co&#x02010;occur (<italic toggle="yes">n</italic>&#x02009;=&#x02009;18/2,82,666 alleles). These two variants were classified as &#x02018;Conflicting Classifications&#x02019; in ClinVar, all in silico methods predicted the p.C296Y variant to be benign, while the p.Y292C variant was predicted to be pathogenic by 4/5 tools, which suggests the haplotype might affect the function of SPRED1.</p><p>We next looked at genes associated with other cancers (Table&#x000a0;<xref rid="pcmr13199-supitem-0003" ref-type="supplementary-material">S3</xref>) and focused on rare (gnomAD VAF &#x02264;&#x02009;5&#x02009;&#x000d7; 10<sup>&#x02212;4</sup>) pathogenic variants. Six patients carried at least one pathogenic variant in cancer&#x02010;related genes. This included two patients carrying PTVs in the DNA repair genes <italic toggle="yes">ATR</italic> or <italic toggle="yes">BRIP1</italic>. PTVs in <italic toggle="yes">ATR</italic> have been associated with oropharyngeal cancer and nonmelanoma skin cancer (Tanaka et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0047" ref-type="bibr">2012</xref>); the carrier in our cohort had bilateral breast cancer (62 and 68&#x02009;years) in addition to UM and CM. PTVs in <italic toggle="yes">BRIP1</italic> have been associated with ovarian cancer (Rafnar et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0040" ref-type="bibr">2011</xref>); the carrier in our cohort had no additional primary cancer diagnoses (49&#x02009;years). Two patients carried the likely pathogenic variant c.3226C&#x0003e;T p.(R1076C) in <italic toggle="yes">MSH6</italic>, which has been reported to predispose to Lynch syndrome. Pathogenic variants in <italic toggle="yes">MSH6</italic> have been associated with cancers other than colorectal carcinomas, including endometrial (Hendriks et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0016" ref-type="bibr">2004</xref>) and nonmelanoma skin cancers (Barrow et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0006" ref-type="bibr">2009</xref>); however, melanomas have yet to be confirmed in the tumour predisposition spectrum (Liu et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0028" ref-type="bibr">2022</xref>). One carrier of the p.(R1076C) variant had developed lymphoma (76&#x02009;years), while the other had not developed any additional primary cancers (49&#x02009;years). Other pathogenic variants were present in <italic toggle="yes">FANCE</italic>, <italic toggle="yes">XPA</italic> and <italic toggle="yes">ERCC5</italic>, associated with Fanconi anaemia, xeroderma pigmentosum (XP) group A and XP group G, respectively. Patients with Fanconi anaemia can have skin pigmentation and ophthalmic anomalies, as well as increased risk of cancers, including haematological malignancies and skin cancers (Mehta and Ebens&#x000a0;<xref rid="pcmr13199-bib-0031" ref-type="bibr">1993</xref>). Aside from UM and CM the carrier in our cohort had not developed any further malignancies by their seventh decade. XP is a recessive disorder leading to &#x0003e; 10,000 times greater risk of skin cancers, &#x0003e;&#x02009;2000 times greater risk of melanoma (Bradford et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0008" ref-type="bibr">2011</xref>) and patients frequently experience ocular anomalies due to UV radiation damage (Kraemer, Lee, and Scotto&#x000a0;<xref rid="pcmr13199-bib-0022" ref-type="bibr">1987</xref>). While XP is a recessive disorder caused by having pathogenic variants in both copies of the gene, it is plausible that carrying a single pathogenic variant is associated with a milder phenotype such as an increased risk of melanoma. There is a precedent for this, with variants causing the recessive oculocutaneous albinism syndromes increasing CM risk in carriers of one pathogenic allele in melanoma families (Goldstein et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0012" ref-type="bibr">2017</xref>; Nathan et&#x000a0;al.&#x000a0;<xref rid="pcmr13199-bib-0036" ref-type="bibr">2019</xref>).</p><p>One patient carried pathogenic variants in <italic toggle="yes">FBXW7</italic> (c.1393C&#x0003e;T p.(R465C)) and <italic toggle="yes">KRAS</italic> (c.437C&#x0003e;T p.(A146V)), which have frequently been observed as somatic mutations in haematological malignancies (COSMIC IDs: COSV55891008 and COSV55498939). This patient was diagnosed with B cell chronic lymphocytic leukaemia 20&#x02009;years prior to sequencing, which means these variants may have arisen somatically.</p><p>In conclusion, eight (10%) UM/CM patients carried a pathogenic mutation in high or medium&#x02010;penetrance melanoma predisposition genes and three (4%) cases carried variants known to predispose to other cancers. Another three cases carried monoallelic variants in cancer genes associated with recessive disorders (XP and Fanconi anaemia), indicating that reduced penetrance of phenotype in these individuals may increase their risk of both UM and CM. While limited by the cohort size, this investigation highlights the need for additional studies to examine the role of this group of genes in melanoma predisposition.</p></sec><sec id="pcmr13199-sec-0002"><title>Author Contributions</title><p>Conceptualisation and supervision: N.K.H.; data curation: P.A.J., J.M.P., H.R.H., A.L.P.; formal analysis and software: P.A.J.; funding acquisition: J.M.P., W.G., N.K.H.; methodology and writing &#x02013; original draft preparation: P.A.J., A.L.P.; resources: L.M., S.W., T.B., W.G.; investigation: M.G.D., K.M.B.; writing &#x02013; review and editing: P.A.J., J.M.P., L.M., S.W., H.R.H., T.B., M.G.D., K.M.B., W.G., N.K.H. and A.L.P.</p></sec><sec sec-type="COI-statement" id="pcmr13199-sec-0004"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="pcmr13199-supitem-0001" position="float" content-type="local-data"><caption><p>
<bold>Table&#x000a0;S1.</bold> Patient characteristics.</p></caption><media xlink:href="PCMR-38-0-s001.xlsx"/></supplementary-material><supplementary-material id="pcmr13199-supitem-0002" position="float" content-type="local-data"><caption><p>
<bold>Table&#x000a0;S2.</bold> Rare nonsynonymous germline variants in cancer&#x02010;associated genes.</p></caption><media xlink:href="PCMR-38-0-s002.xlsx"/></supplementary-material><supplementary-material id="pcmr13199-supitem-0003" position="float" content-type="local-data"><caption><p>
<bold>Table&#x000a0;S3.</bold> List of cancer&#x02010;associated genes analysed.</p></caption><media xlink:href="PCMR-38-0-s003.xlsx"/></supplementary-material></sec></body><back><ack id="pcmr13199-sec-0003"><title>Acknowledgments</title><p>This study was funded by the National Health and Medical Research Council (APP1195581), the St Mary's Anglican Parish of Kangaroo Point, memorial donor honouring Nicola Laws and the Buck Off Melanoma community. A.L.P. was supported by High Island Enterprise grant HMS9353763. We are indebted to the patients and their families for their participation and invaluable contribution to this study, and the many health professionals involved in their care. We acknowledge the support of Sullivan Nicolaides Pathology, the Australian cancer registries and the Terrace Eye Centre staff. Open access publishing facilitated by The University of Queensland, as part of the Wiley &#x02010; The University of Queensland agreement via the Council of Australian University Librarians.</p></ack><sec sec-type="data-availability" id="pcmr13199-sec-0006"><title>Data Availability Statement</title><p>Sequence data has been deposited at the European Genome&#x02010;phenome Archive and are available under accession numbers EGAS00001001552 and EGAS00001007584.</p></sec><ref-list content-type="cited-references" id="pcmr13199-bibl-0001"><title>References</title><ref id="pcmr13199-bib-0001"><mixed-citation publication-type="journal" id="pcmr13199-cit-0001">
<string-name>
<surname>Abdel&#x02010;Rahman</surname>, <given-names>M. H.</given-names>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Pilarski</surname>
</string-name>, <string-name>
<given-names>C. M.</given-names>
<surname>Cebulla</surname>
</string-name>, et&#x000a0;al. <year>2011</year>. &#x0201c;<article-title>Germline BAP1 Mutation Predisposes to Uveal Melanoma, Lung Adenocarcinoma, Meningioma, and Other Cancers</article-title>.&#x0201d; <source>Journal of Medical Genetics</source>
<volume>48</volume>, no. <issue>12</issue>: <fpage>856</fpage>&#x02013;<lpage>859</lpage>. <pub-id pub-id-type="doi">10.1136/jmedgenet-2011-100156</pub-id>.<pub-id pub-id-type="pmid">21941004</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0002"><mixed-citation publication-type="journal" id="pcmr13199-cit-0002">
<string-name>
<surname>Abdel&#x02010;Rahman</surname>, <given-names>M. H.</given-names>
</string-name>, <string-name>
<given-names>K. M.</given-names>
<surname>Sample</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Pilarski</surname>
</string-name>, et&#x000a0;al. <year>2020</year>. &#x0201c;<article-title>Whole Exome Sequencing Identifies Candidate Genes Associated With Hereditary Predisposition to Uveal Melanoma</article-title>.&#x0201d; <source>Ophthalmology</source>
<volume>127</volume>, no. <issue>5</issue>: <fpage>668</fpage>&#x02013;<lpage>678</lpage>. <pub-id pub-id-type="doi">10.1016/j.ophtha.2019.11.009</pub-id>.<pub-id pub-id-type="pmid">32081490</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0003"><mixed-citation publication-type="journal" id="pcmr13199-cit-0003">
<string-name>
<surname>Ablain</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Xu</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Rothschild</surname>
</string-name>, et&#x000a0;al. <year>2018</year>. &#x0201c;<article-title>Human Tumor Genomics and Zebrafish Modeling Identify SPRED1 Loss as a Driver of Mucosal Melanoma</article-title>.&#x0201d; <source>Science</source>
<volume>362</volume>, no. <issue>6418</issue>: <fpage>1055</fpage>&#x02013;<lpage>1060</lpage>. <pub-id pub-id-type="doi">10.1126/science.aau6509</pub-id>.<pub-id pub-id-type="pmid">30385465</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0004"><mixed-citation publication-type="journal" id="pcmr13199-cit-0004">
<string-name>
<surname>Adzhubei</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<given-names>D. M.</given-names>
<surname>Jordan</surname>
</string-name>, and <string-name>
<given-names>S. R.</given-names>
<surname>Sunyaev</surname>
</string-name>. <year>2013</year>. &#x0201c;<article-title>Predicting Functional Effect of Human Missense Mutations Using PolyPhen&#x02010;2</article-title>.&#x0201d; <source>Current Protocols in Human Genetics</source>
<volume>Chapter&#x000a0;7</volume>, no. <issue>Unit 7</issue>: <fpage>20</fpage>. <pub-id pub-id-type="doi">10.1002/0471142905.hg0720s76</pub-id>.</mixed-citation></ref><ref id="pcmr13199-bib-0005"><mixed-citation publication-type="journal" id="pcmr13199-cit-0005">
<string-name>
<surname>Bailey</surname>, <given-names>J. A.</given-names>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Gu</surname>
</string-name>, <string-name>
<given-names>R. A.</given-names>
<surname>Clark</surname>
</string-name>, et&#x000a0;al. <year>2002</year>. &#x0201c;<article-title>Recent Segmental Duplications in the Human Genome</article-title>.&#x0201d; <source>Science</source>
<volume>297</volume>, no. <issue>5583</issue>: <fpage>1003</fpage>&#x02013;<lpage>1007</lpage>. <pub-id pub-id-type="doi">10.1126/science.1072047</pub-id>.<pub-id pub-id-type="pmid">12169732</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0006"><mixed-citation publication-type="journal" id="pcmr13199-cit-0006">
<string-name>
<surname>Barrow</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Robinson</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Alduaij</surname>
</string-name>, et&#x000a0;al. <year>2009</year>. &#x0201c;<article-title>Cumulative Lifetime Incidence of Extracolonic Cancers in Lynch Syndrome: A Report of 121 Families With Proven Mutations</article-title>.&#x0201d; <source>Clinical Genetics</source>
<volume>75</volume>, no. <issue>2</issue>: <fpage>141</fpage>&#x02013;<lpage>149</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-0004.2008.01125.x</pub-id>.<pub-id pub-id-type="pmid">19215248</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0007"><mixed-citation publication-type="journal" id="pcmr13199-cit-0007">
<string-name>
<surname>Bertolotto</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Lesueur</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Giuliano</surname>
</string-name>, et&#x000a0;al. <year>2011</year>. &#x0201c;<article-title>A SUMOylation&#x02014;Defective MITF Germline Mutation Predisposes to Melanoma and Renal Carcinoma</article-title>.&#x0201d; <source>Nature</source>
<volume>480</volume>, no. <issue>7375</issue>: <fpage>94</fpage>&#x02013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1038/nature10539</pub-id>.<pub-id pub-id-type="pmid">22012259</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0008"><mixed-citation publication-type="journal" id="pcmr13199-cit-0008">
<string-name>
<surname>Bradford</surname>, <given-names>P. T.</given-names>
</string-name>, <string-name>
<given-names>A. M.</given-names>
<surname>Goldstein</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Tamura</surname>
</string-name>, et&#x000a0;al. <year>2011</year>. &#x0201c;<article-title>Cancer and Neurologic Degeneration in Xeroderma Pigmentosum: Long Term Follow&#x02010;Up Characterises the Role of DNA Repair</article-title>.&#x0201d; <source>Journal of Medical Genetics</source>
<volume>48</volume>, no. <issue>3</issue>: <fpage>168</fpage>&#x02013;<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.2010.083022</pub-id>.<pub-id pub-id-type="pmid">21097776</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0009"><mixed-citation publication-type="journal" id="pcmr13199-cit-0009">
<string-name>
<surname>Del Bino</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Sok</surname>
</string-name>, and <string-name>
<given-names>F.</given-names>
<surname>Bernerd</surname>
</string-name>. <year>2013</year>. &#x0201c;<article-title>Assessment of Ultraviolet&#x02010;Radiation&#x02010;Induced DNA Damage Within Melanocytes in Skin of Different Constitutive Pigmentation</article-title>.&#x0201d; <source>British Journal of Dermatology</source>
<volume>168</volume>, no. <issue>5</issue>: <fpage>1120</fpage>&#x02013;<lpage>1123</lpage>. <pub-id pub-id-type="doi">10.1111/bjd.12201</pub-id>.<pub-id pub-id-type="pmid">23550734</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0010"><mixed-citation publication-type="journal" id="pcmr13199-cit-0010">
<string-name>
<surname>Derrien</surname>, <given-names>A. C.</given-names>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Houy</surname>
</string-name>, <string-name>
<given-names>O.</given-names>
<surname>Ganier</surname>
</string-name>, et&#x000a0;al. <year>2022</year>. &#x0201c;<article-title>Functional Characterization of 5p15.33 Risk Locus in Uveal Melanoma Reveals rs452384 as a Functional Variant and NKX2.4 as an Allele&#x02010;Specific Interactor</article-title>.&#x0201d; <source>American Journal of Human Genetics</source>
<volume>109</volume>, no. <issue>12</issue>: <fpage>2196</fpage>&#x02013;<lpage>2209</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2022.11.004</pub-id>.<pub-id pub-id-type="pmid">36459980</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0011"><mixed-citation publication-type="journal" id="pcmr13199-cit-0011">
<string-name>
<surname>Ferguson</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Vogelsang</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Ucisik&#x02010;Akkaya</surname>
</string-name>, et&#x000a0;al. <year>2016</year>. &#x0201c;<article-title>Genetic Markers of Pigmentation Are Novel Risk Loci for Uveal Melanoma</article-title>.&#x0201d; <source>Scientific Reports</source>
<volume>6</volume>: <elocation-id>31191</elocation-id>. <pub-id pub-id-type="doi">10.1038/srep31191</pub-id>.<pub-id pub-id-type="pmid">27499155</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0012"><mixed-citation publication-type="journal" id="pcmr13199-cit-0012">
<string-name>
<surname>Goldstein</surname>, <given-names>A. M.</given-names>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Xiao</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Sampson</surname>
</string-name>, et&#x000a0;al. <year>2017</year>. &#x0201c;<article-title>Rare Germline Variants in Known Melanoma Susceptibility Genes in Familial Melanoma</article-title>.&#x0201d; <source>Human Molecular Genetics</source>
<volume>26</volume>, no. <issue>24</issue>: <fpage>4886</fpage>&#x02013;<lpage>4895</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddx368</pub-id>.<pub-id pub-id-type="pmid">29036293</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0013"><mixed-citation publication-type="journal" id="pcmr13199-cit-0013">
<string-name>
<surname>Goto</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>R. W.</given-names>
<surname>Miller</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Ishikawa</surname>
</string-name>, and <string-name>
<given-names>H.</given-names>
<surname>Sugano</surname>
</string-name>. <year>1996</year>. &#x0201c;<article-title>Excess of Rare Cancers in Werner Syndrome (Adult Progeria)</article-title>.&#x0201d; <source>Cancer Epidemiology, Biomarkers &#x00026; Prevention</source>
<volume>5</volume>, no. <issue>4</issue>: <fpage>239</fpage>&#x02013;<lpage>246</lpage>. Retrieved from <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/8722214" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/pubmed/8722214</ext-link>.</mixed-citation></ref><ref id="pcmr13199-bib-0015"><mixed-citation publication-type="journal" id="pcmr13199-cit-0015">
<string-name>
<surname>Hearle</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<given-names>B. E.</given-names>
<surname>Damato</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Humphreys</surname>
</string-name>, et&#x000a0;al. <year>2003</year>. &#x0201c;<article-title>Contribution of Germline Mutations in BRCA2, P16(INK4A), P14(ARF) and P15 to Uveal Melanoma</article-title>.&#x0201d; <source>Investigative Ophthalmology &#x00026; Visual Science</source>
<volume>44</volume>, no. <issue>2</issue>: <fpage>458</fpage>&#x02013;<lpage>462</lpage>. <pub-id pub-id-type="doi">10.1167/iovs.02-0026</pub-id>.<pub-id pub-id-type="pmid">12556369</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0016"><mixed-citation publication-type="journal" id="pcmr13199-cit-0016">
<string-name>
<surname>Hendriks</surname>, <given-names>Y. M.</given-names>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Wagner</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Morreau</surname>
</string-name>, et&#x000a0;al. <year>2004</year>. &#x0201c;<article-title>Cancer Risk in Hereditary Nonpolyposis Colorectal Cancer Due to MSH6 Mutations: Impact on Counseling and Surveillance</article-title>.&#x0201d; <source>Gastroenterology</source>
<volume>127</volume>, no. <issue>1</issue>: <fpage>17</fpage>&#x02013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2004.03.068</pub-id>.<pub-id pub-id-type="pmid">15236168</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0017"><mixed-citation publication-type="journal" id="pcmr13199-cit-0017">
<string-name>
<surname>Ioannidis</surname>, <given-names>N. M.</given-names>
</string-name>, <string-name>
<given-names>J. H.</given-names>
<surname>Rothstein</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Pejaver</surname>
</string-name>, et&#x000a0;al. <year>2016</year>. &#x0201c;<article-title>REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants</article-title>.&#x0201d; <source>American Journal of Human Genetics</source>
<volume>99</volume>, no. <issue>4</issue>: <fpage>877</fpage>&#x02013;<lpage>885</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2016.08.016</pub-id>.<pub-id pub-id-type="pmid">27666373</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0018"><mixed-citation publication-type="journal" id="pcmr13199-cit-0018">
<string-name>
<surname>Kannengiesser</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<given-names>M. F.</given-names>
<surname>Avril</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Spatz</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Laud</surname>
</string-name>, <string-name>
<given-names>G. M.</given-names>
<surname>Lenoir</surname>
</string-name>, and <string-name>
<given-names>B.</given-names>
<surname>Bressac&#x02010;de&#x02010;Paillerets</surname>
</string-name>. <year>2003</year>. &#x0201c;<article-title>CDKN2A as a Uveal and Cutaneous Melanoma Susceptibility Gene</article-title>.&#x0201d; <source>Genes, Chromosomes &#x00026; Cancer</source>
<volume>38</volume>, no. <issue>3</issue>: <fpage>265</fpage>&#x02013;<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1002/gcc.10286</pub-id>.<pub-id pub-id-type="pmid">14506702</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0019"><mixed-citation publication-type="journal" id="pcmr13199-cit-0019">
<string-name>
<surname>Karczewski</surname>, <given-names>K. J.</given-names>
</string-name>, <string-name>
<given-names>L. C.</given-names>
<surname>Francioli</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Tiao</surname>
</string-name>, et&#x000a0;al. <year>2020</year>. &#x0201c;<article-title>The Mutational Constraint Spectrum Quantified From Variation in 141,456 Humans</article-title>.&#x0201d; <source>Nature</source>
<volume>581</volume>, no. <issue>7809</issue>: <fpage>434</fpage>&#x02013;<lpage>443</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-020-2308-7</pub-id>.<pub-id pub-id-type="pmid">32461654</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0020"><mixed-citation publication-type="journal" id="pcmr13199-cit-0020">
<string-name>
<surname>Kircher</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>D. M.</given-names>
<surname>Witten</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Jain</surname>
</string-name>, <string-name>
<given-names>B. J.</given-names>
<surname>O'Roak</surname>
</string-name>, <string-name>
<given-names>G. M.</given-names>
<surname>Cooper</surname>
</string-name>, and <string-name>
<given-names>J.</given-names>
<surname>Shendure</surname>
</string-name>. <year>2014</year>. &#x0201c;<article-title>A General Framework for Estimating the Relative Pathogenicity of Human Genetic Variants</article-title>.&#x0201d; <source>Nature Genetics</source>
<volume>46</volume>, no. <issue>3</issue>: <fpage>310</fpage>&#x02013;<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2892</pub-id>.<pub-id pub-id-type="pmid">24487276</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0021"><mixed-citation publication-type="journal" id="pcmr13199-cit-0021">
<string-name>
<surname>Kitano</surname>, <given-names>K.</given-names>
</string-name>
<year>2014</year>. &#x0201c;<article-title>Structural Mechanisms of Human RecQ Helicases WRN and BLM</article-title>.&#x0201d; <source>Frontiers in Genetics</source>
<volume>5</volume>: <elocation-id>366</elocation-id>. <pub-id pub-id-type="doi">10.3389/fgene.2014.00366</pub-id>.<pub-id pub-id-type="pmid">25400656</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0022"><mixed-citation publication-type="journal" id="pcmr13199-cit-0022">
<string-name>
<surname>Kraemer</surname>, <given-names>K. H.</given-names>
</string-name>, <string-name>
<given-names>M. M.</given-names>
<surname>Lee</surname>
</string-name>, and <string-name>
<given-names>J.</given-names>
<surname>Scotto</surname>
</string-name>. <year>1987</year>. &#x0201c;<article-title>Xeroderma Pigmentosum: Cutaneous, Ocular, and Neurologic Abnormalities in 830 Published Cases</article-title>.&#x0201d; <source>Archives of Dermatology</source>
<volume>123</volume>, no. <issue>2</issue>: <fpage>241</fpage>&#x02013;<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1001/archderm.123.2.241</pub-id>.<pub-id pub-id-type="pmid">3545087</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0023"><mixed-citation publication-type="journal" id="pcmr13199-cit-0023">
<string-name>
<surname>Landi</surname>, <given-names>M. T.</given-names>
</string-name>, <string-name>
<given-names>D. T.</given-names>
<surname>Bishop</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>MacGregor</surname>
</string-name>, et&#x000a0;al. <year>2020</year>. &#x0201c;<article-title>Genome&#x02010;Wide Association Meta&#x02010;Analyses Combining Multiple Risk Phenotypes Provide Insights Into the Genetic Architecture of Cutaneous Melanoma Susceptibility</article-title>.&#x0201d; <source>Nature Genetics</source>
<volume>52</volume>, no. <issue>5</issue>: <fpage>494</fpage>&#x02013;<lpage>504</lpage>. <pub-id pub-id-type="doi">10.1038/s41588-020-0611-8</pub-id>.<pub-id pub-id-type="pmid">32341527</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0024"><mixed-citation publication-type="journal" id="pcmr13199-cit-0024">
<string-name>
<surname>Li</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Zhi</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Wang</surname>
</string-name>, and <string-name>
<given-names>X.</given-names>
<surname>Liu</surname>
</string-name>. <year>2022</year>. &#x0201c;<article-title>MetaRNN: Differentiating Rare Pathogenic and Rare Benign Missense SNVs and InDels Using Deep Learning</article-title>.&#x0201d; <source>Genome Medicine</source>
<volume>14</volume>, no. <issue>1</issue>: <fpage>115</fpage>. <pub-id pub-id-type="doi">10.1186/s13073-022-01120-z</pub-id>.<pub-id pub-id-type="pmid">36209109</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0025"><mixed-citation publication-type="journal" id="pcmr13199-cit-0025">
<string-name>
<surname>Li</surname>, <given-names>H.</given-names>
</string-name>, and <string-name>
<given-names>R.</given-names>
<surname>Durbin</surname>
</string-name>. <year>2009</year>. &#x0201c;<article-title>Fast and Accurate Short Read Alignment With Burrows&#x02010;Wheeler Transform</article-title>.&#x0201d; <source>Bioinformatics</source>
<volume>25</volume>, no. <issue>14</issue>: <fpage>1754</fpage>&#x02013;<lpage>1760</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btp324</pub-id>.<pub-id pub-id-type="pmid">19451168</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0026"><mixed-citation publication-type="journal" id="pcmr13199-cit-0026">
<string-name>
<surname>Li</surname>, <given-names>H.</given-names>
</string-name>, and <string-name>
<given-names>R.</given-names>
<surname>Durbin</surname>
</string-name>. <year>2010</year>. &#x0201c;<article-title>Fast and Accurate Long&#x02010;Read Alignment With Burrows&#x02014;Wheeler Transform</article-title>.&#x0201d; <source>Bioinformatics</source>
<volume>26</volume>, no. <issue>5</issue>: <fpage>589</fpage>&#x02013;<lpage>595</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btp698</pub-id>.<pub-id pub-id-type="pmid">20080505</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0027"><mixed-citation publication-type="journal" id="pcmr13199-cit-0027">
<string-name>
<surname>Liu</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Mou</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Dong</surname>
</string-name>, and <string-name>
<given-names>Y.</given-names>
<surname>Tu</surname>
</string-name>. <year>2020</year>. &#x0201c;<article-title>dbNSFP v4: A Comprehensive Database of Transcript&#x02010;Specific Functional Predictions and Annotations for Human Nonsynonymous and Splice&#x02010;Site SNVs</article-title>.&#x0201d; <source>Genome Medicine</source>
<volume>12</volume>, no. <issue>1</issue>: <fpage>103</fpage>. <pub-id pub-id-type="doi">10.1186/s13073-020-00803-9</pub-id>.<pub-id pub-id-type="pmid">33261662</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0028"><mixed-citation publication-type="journal" id="pcmr13199-cit-0028">
<string-name>
<surname>Liu</surname>, <given-names>Y. L.</given-names>
</string-name>, <string-name>
<given-names>K. A.</given-names>
<surname>Cadoo</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Maio</surname>
</string-name>, et&#x000a0;al. <year>2022</year>. &#x0201c;<article-title>Early Age of Onset and Broad Cancer Spectrum Persist in MSH6&#x02014;and PMS2&#x02010;Associated Lynch Syndrome</article-title>.&#x0201d; <source>Genetics in Medicine</source>
<volume>24</volume>, no. <issue>6</issue>: <fpage>1187</fpage>&#x02013;<lpage>1195</lpage>. <pub-id pub-id-type="doi">10.1016/j.gim.2022.02.016</pub-id>.<pub-id pub-id-type="pmid">35346574</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0029"><mixed-citation publication-type="journal" id="pcmr13199-cit-0029">
<string-name>
<surname>McKenna</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Hanna</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Banks</surname>
</string-name>, et&#x000a0;al. <year>2010</year>. &#x0201c;<article-title>The Genome Analysis Toolkit: A MapReduce Framework for Analyzing Next&#x02010;Generation DNA Sequencing Data</article-title>.&#x0201d; <source>Genome Research</source>
<volume>20</volume>, no. <issue>9</issue>: <fpage>1297</fpage>&#x02013;<lpage>1303</lpage>. <pub-id pub-id-type="doi">10.1101/gr.107524.110</pub-id>.<pub-id pub-id-type="pmid">20644199</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0030"><mixed-citation publication-type="journal" id="pcmr13199-cit-0030">
<string-name>
<surname>McLaren</surname>, <given-names>W.</given-names>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Gil</surname>
</string-name>, <string-name>
<given-names>S. E.</given-names>
<surname>Hunt</surname>
</string-name>, et&#x000a0;al. <year>2016</year>. &#x0201c;<article-title>The Ensembl Variant Effect Predictor</article-title>.&#x0201d; <source>Genome Biology</source>
<volume>17</volume>, no. <issue>1</issue>: <fpage>122</fpage>. <pub-id pub-id-type="doi">10.1186/s13059-016-0974-4</pub-id>.<pub-id pub-id-type="pmid">27268795</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0031"><mixed-citation publication-type="book" id="pcmr13199-cit-0031">
<string-name>
<surname>Mehta</surname>, <given-names>P. A.</given-names>
</string-name>, and <string-name>
<given-names>C.</given-names>
<surname>Ebens</surname>
</string-name>. <year>1993</year>. &#x0201c;<part-title>Fanconi Anemia</part-title>.&#x0201d; In <source>GeneReviews [Internet]</source>, edited by <person-group person-group-type="editor">
<string-name>
<given-names>M. P.</given-names>
<surname>Adam</surname>
</string-name>
</person-group>, <person-group person-group-type="editor">
<string-name>
<given-names>G. M.</given-names>
<surname>Mirzaa</surname>
</string-name>
</person-group>, <person-group person-group-type="editor">
<string-name>
<given-names>R. A.</given-names>
<surname>Pagon</surname>
</string-name>
</person-group>, <person-group person-group-type="editor">
<string-name>
<given-names>S. E.</given-names>
<surname>Wallace</surname>
</string-name>
</person-group>, <person-group person-group-type="editor">
<string-name>
<given-names>L. J. H.</given-names>
<surname>Bean</surname>
</string-name>
</person-group>, <person-group person-group-type="editor">
<string-name>
<given-names>K. W.</given-names>
<surname>Gripp</surname>
</string-name>
</person-group>, and <person-group person-group-type="editor">
<string-name>
<given-names>A.</given-names>
<surname>Amemiya</surname>
</string-name>
</person-group>. <publisher-loc>Seattle, WA</publisher-loc>: <publisher-name>University of Washington</publisher-name>.</mixed-citation></ref><ref id="pcmr13199-bib-0032"><mixed-citation publication-type="journal" id="pcmr13199-cit-0032">
<string-name>
<surname>Mobuchon</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Battistella</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Bardel</surname>
</string-name>, et&#x000a0;al. <year>2017</year>. &#x0201c;<article-title>A GWAS in Uveal Melanoma Identifies Risk Polymorphisms in the CLPTM1L Locus</article-title>.&#x0201d; <source>NPJ Genomic Medicine</source>
<volume>2</volume>. <pub-id pub-id-type="doi">10.1038/s41525-017-0008-5</pub-id>.</mixed-citation></ref><ref id="pcmr13199-bib-0033"><mixed-citation publication-type="journal" id="pcmr13199-cit-0033">
<string-name>
<surname>Mobuchon</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<given-names>A. C.</given-names>
<surname>Derrien</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Houy</surname>
</string-name>, et&#x000a0;al. <year>2022</year>. &#x0201c;<article-title>Different Pigmentation Risk Loci for High&#x02010;Risk Monosomy 3 and Low&#x02010;Risk Disomy 3 Uveal Melanomas</article-title>.&#x0201d; <source>Journal of the National Cancer Institute</source>
<volume>114</volume>, no. <issue>2</issue>: <fpage>302</fpage>&#x02013;<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1093/jnci/djab167</pub-id>.<pub-id pub-id-type="pmid">34424336</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0034"><mixed-citation publication-type="journal" id="pcmr13199-cit-0034">
<string-name>
<surname>Nathan</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<given-names>J. C.</given-names>
<surname>Hassel</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Rutkowski</surname>
</string-name>, et&#x000a0;al. <year>2021</year>. &#x0201c;<article-title>Overall Survival Benefit With Tebentafusp in Metastatic Uveal Melanoma</article-title>.&#x0201d; <source>New England Journal of Medicine</source>
<volume>385</volume>, no. <issue>13</issue>: <fpage>1196</fpage>&#x02013;<lpage>1206</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa2103485</pub-id>.<pub-id pub-id-type="pmid">34551229</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0035"><mixed-citation publication-type="journal" id="pcmr13199-cit-0035">
<string-name>
<surname>Nathan</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<given-names>P. A.</given-names>
<surname>Johansson</surname>
</string-name>, <string-name>
<given-names>J. M.</given-names>
<surname>Palmer</surname>
</string-name>, et&#x000a0;al. <year>2021</year>. &#x0201c;<article-title>A Rare Missense Variant in Protection of Telomeres 1 (POT1) Predisposes to a Range of Haematological Malignancies</article-title>.&#x0201d; <source>British Journal of Haematology</source>
<volume>192</volume>, no. <issue>2</issue>: <fpage>e57</fpage>&#x02013;<lpage>e60</lpage>. <pub-id pub-id-type="doi">10.1111/bjh.17218</pub-id>.<pub-id pub-id-type="pmid">33216348</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0036"><mixed-citation publication-type="journal" id="pcmr13199-cit-0036">
<string-name>
<surname>Nathan</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<given-names>P. A.</given-names>
<surname>Johansson</surname>
</string-name>, <string-name>
<given-names>J. M.</given-names>
<surname>Palmer</surname>
</string-name>, et&#x000a0;al. <year>2019</year>. &#x0201c;<article-title>Germline Variants in Oculocutaneous Albinism Genes and Predisposition to Familial Cutaneous Melanoma</article-title>.&#x0201d; <source>Pigment Cell &#x00026; Melanoma Research</source>
<volume>32</volume>, no. <issue>6</issue>: <fpage>854</fpage>&#x02013;<lpage>863</lpage>. <pub-id pub-id-type="doi">10.1111/pcmr.12804</pub-id>.<pub-id pub-id-type="pmid">31233279</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0037"><mixed-citation publication-type="journal" id="pcmr13199-cit-0037">
<string-name>
<surname>Nathan</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<given-names>J. M.</given-names>
<surname>Palmer</surname>
</string-name>, <string-name>
<given-names>P. A.</given-names>
<surname>Johansson</surname>
</string-name>, et&#x000a0;al. <year>2021</year>. &#x0201c;<article-title>Loss&#x02010;of&#x02010;Function Variants in POT1 Predispose to Uveal Melanoma</article-title>.&#x0201d; <source>Journal of Medical Genetics</source>
<volume>58</volume>, no. <issue>4</issue>: <fpage>234</fpage>&#x02013;<lpage>236</lpage>. <pub-id pub-id-type="doi">10.1136/jmedgenet-2020-107098</pub-id>.<pub-id pub-id-type="pmid">32907878</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0038"><mixed-citation publication-type="journal" id="pcmr13199-cit-0038">
<string-name>
<surname>Newell</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<given-names>P. A.</given-names>
<surname>Johansson</surname>
</string-name>, <string-name>
<given-names>J. S.</given-names>
<surname>Wilmott</surname>
</string-name>, et&#x000a0;al. <year>2022</year>. &#x0201c;<article-title>Comparative Genomics Provides Etiologic and Biological Insight Into Melanoma Subtypes</article-title>.&#x0201d; <source>Cancer Discovery</source>
<volume>12</volume>, no. <issue>12</issue>: <fpage>2856</fpage>&#x02013;<lpage>2879</lpage>. <pub-id pub-id-type="doi">10.1158/2159-8290.CD-22-0603</pub-id>.<pub-id pub-id-type="pmid">36098958</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0039"><mixed-citation publication-type="journal" id="pcmr13199-cit-0039">
<string-name>
<surname>Ng</surname>, <given-names>P. C.</given-names>
</string-name>, and <string-name>
<given-names>S.</given-names>
<surname>Henikoff</surname>
</string-name>. <year>2003</year>. &#x0201c;<article-title>SIFT: Predicting Amino Acid Changes That Affect Protein Function</article-title>.&#x0201d; <source>Nucleic Acids Research</source>
<volume>31</volume>, no. <issue>13</issue>: <fpage>3812</fpage>&#x02013;<lpage>3814</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkg509</pub-id>.<pub-id pub-id-type="pmid">12824425</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0040"><mixed-citation publication-type="journal" id="pcmr13199-cit-0040">
<string-name>
<surname>Rafnar</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<given-names>D. F.</given-names>
<surname>Gudbjartsson</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Sulem</surname>
</string-name>, et&#x000a0;al. <year>2011</year>. &#x0201c;<article-title>Mutations in BRIP1 Confer High Risk of Ovarian Cancer</article-title>.&#x0201d; <source>Nature Genetics</source>
<volume>43</volume>, no. <issue>11</issue>: <fpage>1104</fpage>&#x02013;<lpage>1107</lpage>. <pub-id pub-id-type="doi">10.1038/ng.955</pub-id>.<pub-id pub-id-type="pmid">21964575</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0041"><mixed-citation publication-type="journal" id="pcmr13199-cit-0041">
<string-name>
<surname>Rizvi</surname>, <given-names>N. A.</given-names>
</string-name>, <string-name>
<given-names>M. D.</given-names>
<surname>Hellmann</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Snyder</surname>
</string-name>, et&#x000a0;al. <year>2015</year>. &#x0201c;<article-title>Cancer Immunology. Mutational Landscape Determines Sensitivity to PD&#x02010;1 Blockade in Non&#x02010;Small Cell Lung Cancer</article-title>.&#x0201d; <source>Science</source>
<volume>348</volume>, no. <issue>6230</issue>: <fpage>124</fpage>&#x02013;<lpage>128</lpage>. <pub-id pub-id-type="doi">10.1126/science.aaa1348</pub-id>.<pub-id pub-id-type="pmid">25765070</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0042"><mixed-citation publication-type="journal" id="pcmr13199-cit-0042">
<string-name>
<surname>Robertson</surname>, <given-names>A. G.</given-names>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Shih</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Yau</surname>
</string-name>, et&#x000a0;al. <year>2017</year>. &#x0201c;<article-title>Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma</article-title>.&#x0201d; <source>Cancer Cell</source>
<volume>32</volume>, no. <issue>2</issue>: <fpage>204</fpage>&#x02013;<lpage>220.e15</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccell.2017.07.003</pub-id>.<pub-id pub-id-type="pmid">28810145</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0043"><mixed-citation publication-type="journal" id="pcmr13199-cit-0043">
<string-name>
<surname>Robles&#x02010;Espinoza</surname>, <given-names>C. D.</given-names>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Harland</surname>
</string-name>, <string-name>
<given-names>A. J.</given-names>
<surname>Ramsay</surname>
</string-name>, et&#x000a0;al. <year>2014</year>. &#x0201c;<article-title>POT1 Loss&#x02010;of&#x02010;Function Variants Predispose to Familial Melanoma</article-title>.&#x0201d; <source>Nature Genetics</source>
<volume>46</volume>, no. <issue>5</issue>: <fpage>478</fpage>&#x02013;<lpage>481</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2947</pub-id>.<pub-id pub-id-type="pmid">24686849</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0044"><mixed-citation publication-type="journal" id="pcmr13199-cit-0044">
<string-name>
<surname>Robles&#x02010;Espinoza</surname>, <given-names>C. D.</given-names>
</string-name>, <string-name>
<given-names>N. D.</given-names>
<surname>Roberts</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Chen</surname>
</string-name>, et&#x000a0;al. <year>2016</year>. &#x0201c;<article-title>Germline MC1R Status Influences Somatic Mutation Burden in Melanoma</article-title>.&#x0201d; <source>Nature Communications</source>
<volume>7</volume>: <elocation-id>12064</elocation-id>. <pub-id pub-id-type="doi">10.1038/ncomms12064</pub-id>.</mixed-citation></ref><ref id="pcmr13199-bib-0045"><mixed-citation publication-type="journal" id="pcmr13199-cit-0045">
<string-name>
<surname>Shi</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<given-names>X. R.</given-names>
<surname>Yang</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Ballew</surname>
</string-name>, et&#x000a0;al. <year>2014</year>. &#x0201c;<article-title>Rare Missense Variants in POT1 Predispose To Familial Cutaneous Malignant Melanoma</article-title>.&#x0201d; <source>Nature Genetics</source>
<volume>46</volume>, no. <issue>5</issue>: <fpage>482</fpage>&#x02013;<lpage>486</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2941</pub-id>.<pub-id pub-id-type="pmid">24686846</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0046"><mixed-citation publication-type="journal" id="pcmr13199-cit-0046">
<string-name>
<surname>Strauch</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Lord</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Niranjan</surname>
</string-name>, and <string-name>
<given-names>D.</given-names>
<surname>Baralle</surname>
</string-name>. <year>2022</year>. &#x0201c;<article-title>CI&#x02010;SpliceAI&#x02010;Improving Machine Learning Predictions of Disease Causing Splicing Variants Using Curated Alternative Splice Sites</article-title>.&#x0201d; <source>PLoS One</source>
<volume>17</volume>, no. <issue>6</issue>: <elocation-id>e0269159</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0269159</pub-id>.<pub-id pub-id-type="pmid">35657932</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0047"><mixed-citation publication-type="journal" id="pcmr13199-cit-0047">
<string-name>
<surname>Tanaka</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Weinel</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Nagy</surname>
</string-name>, et&#x000a0;al. <year>2012</year>. &#x0201c;<article-title>Germline Mutation in ATR in Autosomal&#x02014;Dominant Oropharyngeal Cancer Syndrome</article-title>.&#x0201d; <source>American Journal of Human Genetics</source>
<volume>90</volume>, no. <issue>3</issue>: <fpage>511</fpage>&#x02013;<lpage>517</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2012.01.007</pub-id>.<pub-id pub-id-type="pmid">22341969</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0048"><mixed-citation publication-type="journal" id="pcmr13199-cit-0048">
<string-name>
<surname>Thomsen</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Chattopadhyay</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Hoffmann</surname>
</string-name>, et&#x000a0;al. <year>2020</year>. &#x0201c;<article-title>Genome&#x02010;Wide Study on Uveal Melanoma Patients Finds Association to DNA Repair Gene TDP1</article-title>.&#x0201d; <source>Melanoma Research</source>
<volume>30</volume>, no. <issue>2</issue>: <fpage>166</fpage>&#x02013;<lpage>172</lpage>. <pub-id pub-id-type="doi">10.1097/CMR.0000000000000641</pub-id>.<pub-id pub-id-type="pmid">31626034</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0049"><mixed-citation publication-type="journal" id="pcmr13199-cit-0049">
<string-name>
<surname>Valverde</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Healy</surname>
</string-name>, <string-name>
<given-names>I.</given-names>
<surname>Jackson</surname>
</string-name>, <string-name>
<given-names>J. L.</given-names>
<surname>Rees</surname>
</string-name>, and <string-name>
<given-names>A. J.</given-names>
<surname>Thody</surname>
</string-name>. <year>1995</year>. &#x0201c;<article-title>Variants of the Melanocyte&#x02010;Stimulating Hormone Receptor Gene Are Associated With Red Hair and Fair Skin in Humans</article-title>.&#x0201d; <source>Nature Genetics</source>
<volume>11</volume>, no. <issue>3</issue>: <fpage>328</fpage>&#x02013;<lpage>330</lpage>. <pub-id pub-id-type="doi">10.1038/ng1195-328</pub-id>.<pub-id pub-id-type="pmid">7581459</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0050"><mixed-citation publication-type="journal" id="pcmr13199-cit-0050">
<string-name>
<surname>Van Raamsdonk</surname>, <given-names>C. D.</given-names>
</string-name>, <string-name>
<given-names>K. G.</given-names>
<surname>Griewank</surname>
</string-name>, <string-name>
<given-names>M. B.</given-names>
<surname>Crosby</surname>
</string-name>, et&#x000a0;al. <year>2010</year>. &#x0201c;<article-title>Mutations in GNA11 in Uveal Melanoma</article-title>.&#x0201d; <source>New England Journal of Medicine</source>
<volume>363</volume>, no. <issue>23</issue>: <fpage>2191</fpage>&#x02013;<lpage>2199</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1000584</pub-id>.<pub-id pub-id-type="pmid">21083380</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0051"><mixed-citation publication-type="journal" id="pcmr13199-cit-0051">
<string-name>
<surname>Walpole</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<given-names>A. L.</given-names>
<surname>Pritchard</surname>
</string-name>, <string-name>
<given-names>C. M.</given-names>
<surname>Cebulla</surname>
</string-name>, et&#x000a0;al. <year>2018</year>. &#x0201c;<article-title>Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant&#x02010;Carrying Families Worldwide</article-title>.&#x0201d; <source>Journal of the National Cancer Institute</source>
<volume>110</volume>, no. <issue>12</issue>: <fpage>1328</fpage>&#x02013;<lpage>1341</lpage>. <pub-id pub-id-type="doi">10.1093/jnci/djy171</pub-id>.<pub-id pub-id-type="pmid">30517737</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0052"><mixed-citation publication-type="journal" id="pcmr13199-cit-0052">
<string-name>
<surname>Ye</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<given-names>M. H.</given-names>
<surname>Schulz</surname>
</string-name>, <string-name>
<given-names>Q.</given-names>
<surname>Long</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Apweiler</surname>
</string-name>, and <string-name>
<given-names>Z.</given-names>
<surname>Ning</surname>
</string-name>. <year>2009</year>. &#x0201c;<article-title>Pindel: A Pattern Growth Approach to Detect Break Points of Large Deletions and Medium Sized Insertions From Paired&#x02010;End Short Reads</article-title>.&#x0201d; <source>Bioinformatics</source>
<volume>25</volume>, no. <issue>21</issue>: <fpage>2865</fpage>&#x02013;<lpage>2871</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btp394</pub-id>.<pub-id pub-id-type="pmid">19561018</pub-id>
</mixed-citation></ref><ref id="pcmr13199-bib-0053"><mixed-citation publication-type="journal" id="pcmr13199-cit-0053">
<string-name>
<surname>Yokoyama</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<given-names>S. L.</given-names>
<surname>Woods</surname>
</string-name>, <string-name>
<given-names>G. M.</given-names>
<surname>Boyle</surname>
</string-name>, et&#x000a0;al. <year>2011</year>. &#x0201c;<article-title>A Novel Recurrent Mutation in MITF Predisposes to Familial and Sporadic Melanoma</article-title>.&#x0201d; <source>Nature</source>
<volume>480</volume>, no. <issue>7375</issue>: <fpage>99</fpage>&#x02013;<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1038/nature10630</pub-id>.<pub-id pub-id-type="pmid">22080950</pub-id>
</mixed-citation></ref></ref-list></back></article>